2 testing labs in Serbia get boost from China
Chinese genomics company BGI Group signed an agreement with the Serbian government on Wednesday to help the European country build two coronavirus testing laboratories, as the pandemic continues to rage across the continent.
The two labs, one located in Belgrade, the Serbian capital, and the other in the southern city of Nis, will be capable of testing a combined 3,000 samples per day once they begin to operate, significantly boosting the country's testing capabilities.
The Belgrade lab will be built at the country's national medical center, which is currently being renovated.
"Thank you for what you have done for the Serbian people at this difficult time," Serbian Prime Minister Ana Brnabic told BGI. "We have received support and help from China in medical supplies, experts, technology and experience from our first day of battling the coronavirus. Without Chinese help, we would not be able to win the battle."
Chinese Ambassador to Serbia Chen Bo said the embassy will continue to provide help so that the two labs can begin operating as soon as possible.
Wang Jian, BGI's founder and chairman, said testing is crucial for early detection and control of the coronavirus. It can effectively prevent delays of medical treatment and reduce public panic.
2026-08-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
-
Pharmaceutical and Health Industry Special Study - The Arrival of New Opportunities
-
Accelerate Technological Breakthroughs in Product Innovation and Promote the Industrialization and Application of Innovative Drugs
Recommend Reading
-
Chemicals Are Going Wild: Sulfur Surges 512%, Titanium Dioxide, Polyols and Sulfuric Acid Lose Control
-
China’s Chemical Sector Reports ¥213.39 Billion Profit in Jan–Jul 2025
-
Hengli Sanctions Spill Over: One Barrel of Iranian Crude Pulls an Aromatics Chain Into Risk
-
Propylene Oxide Price Rally Seen as Short-Lived
-
Brazil Slams Chinese Butyl Acrylate with Anti-Dumping Probe—Trade Tensions Heat Up in Specialty Chemicals
-
In August, China's propylene oxide market showed a trend of first declining then rising
-
Coke market mainly maintains stable operation with overall balanced supply and demand in China
-
China NMPA Issues Priority Review Pathway for Four Categories of Chemical Active Pharmaceutical Ingredients, Effective August 1, 2026
-
Cost Benefits Drive July Polyester Staple Fiber Prices to Fluctuate and Rise
-
Crude oil remains in negative territory, another round of retail fuel price cuts in China